Manifold Bio
PrivateLast Round
Series A
Extension
Dec 3, 2024
Total Funding Raised
$78.18M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Manifold Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series A Extension round in December 2024.
Manifold Bio is a biotechnology company that develops a high-throughput in vivo discovery engine integrating multiplexed screening with AI-powered protein design to create tissue-targeted biologics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Manifold Bio Comparables
Compare Manifold Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dyno Therapeutics | 82% | |
| Gate2Brain | 78% | |
| Cenos Therapeutics | 76% |
For institutional investors. Book with your work email.
Manifold Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 3, 2024 | ||||
| Series A | Jul 14, 2022 | ||||
| Seed | Sep 8, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Manifold Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series A |
| Horizons Ventures | Series A |
| Harvard Innovation Launch Lab | Seed |
| Harvard Innovation Labs | Seed |
| Triatomic Capital | Series A |
| Playground Global | Series A, Seed |
| FAST--by GETTYLAB | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 33% MoM, reaching 10.3K.
- Apr 1, 2026
Generative antibody design model mBER is now available.
For institutional investors. Book with your work email.
Manifold Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Manifold Bio's valuation, stock price, and market status.
Is Manifold Bio a public or private company?
Manifold Bio is a private company.
What is the current stock price of Manifold Bio?
Manifold Bio is a private company, so its shares have no public market price. Caplight tracks Manifold Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Manifold Bio worth (valuation)?
Valuation information for Manifold Bio is not publicly available.
Can I buy Manifold Bio stock?
Manifold Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Manifold Bio's last funding round?
Manifold Bio's most recent funding round was Series A Extension on December 3, 2024.
Who are the main investors in Manifold Bio?
Key investors in Manifold Bio include Triatomic Capital, Playground Global, Playground Global.
Will Manifold Bio IPO soon?
No public IPO plans have been announced for Manifold Bio.
How can I track Manifold Bio secondary market activity?
Caplight tracks bids, offers, and trades in Manifold Bio's shares on secondary markets.